Clinical trial
Phase 2 Trial of Indoximod With Chemotherapy and Radiation for Children With Progressive Brain Tumors or Newly Diagnosed DIPG
NCT04049669 is registered in ClinicalTrials.gov with Theodore S. Johnson as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Trial of Indoximod With Chemotherapy and Radiation for Children With Progressive Brain Tumors or Newly Diagnosed DIPG
- Lead sponsor
- Theodore S. Johnson
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- October 2, 2019
- Completion date
- October 2, 2027
- Enrollment
- 130 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.